The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2,3-Difluoro-5-(5-(2,4,5-trifluoro-3-hydroxybenzoyl)thiophen-2-yl)phenyl)-4-fluorobenzenesulfonamide ID: ALA4576023
PubChem CID: 155564371
Max Phase: Preclinical
Molecular Formula: C23H11F6NO4S2
Molecular Weight: 543.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccc(-c2cc(F)c(F)c(NS(=O)(=O)c3ccc(F)cc3)c2)s1)c1cc(F)c(F)c(O)c1F
Standard InChI: InChI=1S/C23H11F6NO4S2/c24-11-1-3-12(4-2-11)36(33,34)30-16-8-10(7-14(25)20(16)28)17-5-6-18(35-17)22(31)13-9-15(26)21(29)23(32)19(13)27/h1-9,30,32H
Standard InChI Key: KAOIHZYOBKLKIX-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
24.9780 -4.6927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5735 -3.9869 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.1645 -4.6901 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7449 -3.9992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7438 -4.8188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4518 -5.2277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1615 -4.8183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1587 -3.9956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4501 -3.5904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8648 -3.5844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2803 -3.5791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0366 -3.5871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9510 -2.7744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1516 -2.6047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7432 -3.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2902 -3.9196 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.9305 -3.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4499 -2.7373 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5983 -4.1449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7853 -4.2268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4532 -4.9726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9339 -5.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7505 -5.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0789 -4.7998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3064 -3.5646 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.2333 -6.2051 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.6027 -6.3816 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.6404 -5.0579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.9852 -3.9906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6915 -3.5834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6921 -2.7666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9805 -2.3586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2772 -2.7681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3993 -2.3572 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.8699 -5.2258 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.4517 -6.0449 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 2 1 0
2 11 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
4 12 1 0
15 17 1 0
17 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
20 25 1 0
23 26 1 0
22 27 1 0
21 28 1 0
11 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 11 1 0
31 34 1 0
7 35 1 0
6 36 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 543.47Molecular Weight (Monoisotopic): 543.0034AlogP: 5.99#Rotatable Bonds: 6Polar Surface Area: 83.47Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.17CX Basic pKa: ┄CX LogP: 6.03CX LogD: 4.82Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.18Np Likeness Score: -1.25
References 1. Abdelsamie AS, Salah M, Siebenbürger L, Merabet A, Scheuer C, Frotscher M, Müller ST, Zierau O, Vollmer G, Menger MD, Laschke MW, van Koppen CJ, Marchais-Oberwinkler S, Hartmann RW.. (2019) Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis., 62 (15): [PMID:31343176 ] [10.1021/acs.jmedchem.9b00932 ]